Table 4 The genotypes of MUC5B promoter polymorphism as regards the smoking status among the 3 studied groups
From: A preliminary study: MUC5B promoter polymorphism and its association with IPF
Genotype | Smokers | Non smokers | P value |
|---|---|---|---|
IPF patients (group I) | Â | Â | Â |
GT and TT | 13 (50%) | 13 (50%) | 0.014 |
GG | 2 (12.5%) | 14 (87.5) | Â |
Other ILD patients (group II) | Â | Â | Â |
GT and TT | 2 (11.8%) | 15 (88.2%) | 0.850 |
GG | 3 (10%) | 27 (90%) | Â |
Control subjects (group III) | Â | Â | Â |
GT and TT | 2 (25%) | 6 (75%) | 0.650 |
GG | 6 (18.8%) | 26 (81.3%) | Â |